Results from this small intervention trial out of New Zealand strongly suggest that 200 mg/d of CoQ10 does not lower blood pressure in patients with metabolic syndrome and unsuccessfully treated hypertension.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content